The frequency, nature, determinants, and impact of long-COVID in Scotland

In a recent study posted to Research Square*, researchers evaluated long-term sequelae of coronavirus disease 2019 (COVID-19) in Scotland. Study:

Read more

SARS-CoV-2 variants BA.4 and BA.5 show substantial immune escape compared with BA.1 and BA.2

In a recent study posted to the bioRxiv* pre-print server, researchers characterized the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Read more

The effectiveness of sotrovimab vs. molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients

In a recent study posted to the medRxiv* preprint server, researchers compared the efficacy of sotrovimab [an intravenously administered neutralizing

Read more

A study on the safety of BNT162b2 COVID vaccine in children under five

In a recent research paper posted to the medRxiv* preprint server, scientists explored the safety of the severe acute respiratory

Read more

Anti-SARS-CoV-2 antibodies from breast milk persist in infants’ digestive tract

Breastfeeding is crucial for a child’s healthy development and growth. Breast milk contains a variety of bioactive molecules, including antibodies.

Read more

Vaccinated individuals with SARS-CoV-2 infection develop virus-specific T cells inside their noses

In a recent study posted to the medRxiv* preprint server, investigators in Singapore showed that severe acute respiratory syndrome coronavirus

Read more

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

The coronavirus disease 2019 (COVID-19) pandemic has prompted expedited vaccine development. Vaccinations have proven to be a safe and effective

Read more

The design of immunogens for the SARS-CoV-2 spike protein using structure-guided epitope grafting and scaffolding methods

In a recent study posted to the bioRxiv* preprint server, researchers designed an efficient vaccine design against severe acute respiratory

Read more